Home › Funds › Kynam Capital Management, LP › VERA
Kynam Capital Management, LP position in VERA
VERA THERAPEUTICS INC · Health Care
Kynam Capital Management, LP reported holding 2,890,059 shares of VERA (VERA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$124.0M, representing 6.85% of its reported portfolio and ranking #5 among its reported holdings. Kynam Capital Management, LP has disclosed VERA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Kynam Capital Management, LP's VERA position evolved
Kynam Capital Management, LP first disclosed a stake in VERA in Q3 2023 at 2,956,053 shares (US$40.5M). The position peaked in Q4 2025 at 3,433,051 shares, worth US$173.8M. Across 12 filings, Kynam Capital Management, LP increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,890,059 shares valued at US$124.0M — a reduction of -508,165 shares quarter over quarter.. Notable position changes include a 58% trim in Q1 2024 (shares fell 16% over the following quarter), a 65% increase in Q1 2025 (shares fell 2% over the following quarter), a 43% increase in Q2 2025 (shares rose 23% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.96M | $40.53M | New |
| Q4 2023 | 3.65M | $56.14M | Add |
| Q1 2024 | 1.53M | $65.84M | Reduce |
| Q2 2024 | 1.54M | $55.85M | Add |
| Q3 2024 | 1.58M | $69.68M | Add |
| Q4 2024 | 1.46M | $61.66M | Reduce |
| Q1 2025 | 2.40M | $57.65M | Add |
| Q2 2025 | 3.43M | $80.74M | Add |
| Q3 2025 | 4.03M | $117.05M | Add |
| Q4 2025 | 3.43M | $173.85M | Reduce |
| Q1 2026 | 3.40M | $136.71M | Reduce |
| Q2 2026 | 2.89M | $124.01M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VERA and 13F data
VERA (VERA THERAPEUTICS INC) is a Health Care company. 39 other funds we track also report a position in VERA — the largest reported positions include Avoro Capital Advisors LLC (US$245.6M), Deep Track Capital, LP (US$171.6M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$168.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VERA
- Avoro Capital Advisors LLC 5.72M sh · $245.61M · Q2 2026
- Deep Track Capital, LP 4.00M sh · $171.64M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 3.92M sh · $168.05M · Q2 2026
- Sofinnova Investments, Inc. 2.79M sh · $119.89M · Q2 2026
- Eversept Partners, LP 2.21M sh · $94.95M · Q2 2026
- Logos Global Management LP 2.20M sh · $94.40M · Q2 2026
- Integral Health Asset Management, LLC 1.75M sh · $75.09M · Q2 2026
- Bellevue Group AG 1.71M sh · $73.41M · Q2 2026
- GREAT POINT PARTNERS LLC 600.84K sh · $25.78M · Q2 2026
- BRAIDWELL LP 564.72K sh · $24.23M · Q2 2026
- Davern Capital Partners, LP 498.83K sh · $21.40M · Q2 2026
More on Kynam Capital Management, LP
FAQ
How long has Kynam Capital Management, LP held VERA?
Kynam Capital Management, LP has disclosed VERA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Kynam Capital Management, LP's current position in VERA?
As of Q2 2026, Kynam Capital Management, LP holds 2.89M shares of VERA (VERA THERAPEUTICS INC), valued at $124.01M, representing 6.85% of its reported portfolio and ranking #5.
Has Kynam Capital Management, LP been buying or selling VERA?
In the latest 13F filing (Q2 2026), Kynam Capital Management, LP reduced its position in VERA. The position peaked in Q4 2025 at 3.43M shares.
Which other funds hold VERA?
Other major institutional holders of VERA include Avoro Capital Advisors LLC, Deep Track Capital, LP, DEERFIELD MANAGEMENT COMPANY, L.P., among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.